VP Business Development | VC-Backed Biotech

VP, Business Development | VC-Backed Biotech | Remote, USA

Location: Remote, USA (Travel as needed)
Salary: Competitive base bonus equity
Sector: Biotechnology | Business Development
Job Type: Full-time | Permanent

Job Description

A high-growth VC-backed biotech in the Oncology space is seeking a VP of Business Development to lead strategic partnerships, licensing, and corporate development. This is an exciting opportunity to drive deal-making, alliances, and investment strategy within a biotech at a critical stage of growth.

Key Responsibilities

• Develop and execute the business development strategy, identifying and securing high-value partnerships.
• Lead in-licensing and out-licensing discussions for assets in preclinical and clinical stages.
• Negotiate and close collaborations, joint ventures, and strategic alliances with biopharma partners.
• Work closely with the executive team on fundraising, M&A, and corporate strategy.
• Build and maintain strong relationships with biopharma, investors, and VC partners.
  
  

Candidate Profile

• 10 years in biotech BD, corporate development, or investment.
• Proven track record of closing deals, partnerships, and licensing agreements.
• Expertise in Oncology, Neurology, or Immunology with a strong understanding of drug development.
• Strong network with biopharma, biotech investors, and VC firms.
• Experience in a VC-backed or emerging biotech is highly desirable.
  
  

Why Apply?

✅ Strategic Leadership - Drive BD, licensing, and corporate partnerships in a high-growth biotech.
✅ Competitive Package - Base salary performance-based bonus equity.
✅ Remote Flexibility - Work from anywhere in the U.S., with travel as required.

Desired Skills and Experience

10 years in biotech BD, corporate development, or investment.
Proven track record of closing deals, partnerships, and licensing agreements.
Expertise in Oncology, Neurology, or Immunology with a strong understanding of drug development.
Strong network with biopharma, biotech investors, and VC firms.
Experience in a VC-backed or emerging biotech is highly desirable.